Sawle G V, Playford E D, Brooks D J, Quinn N, Frackowiak R S
Clinical Sciences Section, Hammersmith Hospital, London, UK.
Brain. 1993 Aug;116 ( Pt 4):853-67. doi: 10.1093/brain/116.4.853.
Nine L-dopa na ve patients with clinically diagnosed parkinsonism were studied using positron emission tomography with 6-L-[18F]fluorodopa ([18F]dopa, a pre-synaptic tracer) and [11C]raclopride (which binds to D2 receptors). Putamen [18F]dopa uptake was reduced in all patients, confirming a loss of function affecting the nigrostriatal projection. In eight patients the putamen with the lowest [18F]dopa uptake (always contralateral to the clinically most affected side) had the highest [11C]raclopride binding, suggesting upregulation of the post-synaptic D2 receptors. In the ninth patient [11C]raclopride binding was lower in the putamen with the lowest [18F]dopa uptake, indicating an additional post-synaptic deficit. All nine patients were shown to be L-dopa responsive. The subsequent clinical course of the former eight patients has been typical of idiopathic Parkinson's disease, whilst the ninth patient has developed postural hypotension, urinary incontinence and respiratory stridor typical of multiple system atrophy. Reduced [11C]raclopride binding in L-dopa naïve parkinsonian patients might serve as a useful early marker of this condition.
对9名临床诊断为帕金森病的初治左旋多巴患者进行了研究,采用正电子发射断层扫描技术,使用6-L-[18F]氟多巴([18F]多巴,一种突触前示踪剂)和[11C]雷氯必利(与D2受体结合)。所有患者壳核的[18F]多巴摄取均降低,证实黑质纹状体投射功能丧失。在8名患者中,[18F]多巴摄取最低的壳核(总是与临床受累最严重的一侧对侧)具有最高的[11C]雷氯必利结合,提示突触后D2受体上调。在第9名患者中,[18F]多巴摄取最低的壳核中[11C]雷氯必利结合较低,表明存在额外的突触后缺陷。所有9名患者均显示对左旋多巴有反应。前8名患者随后的临床病程符合特发性帕金森病的典型表现,而第9名患者出现了多系统萎缩典型的体位性低血压、尿失禁和呼吸喘鸣。初治帕金森病患者中[11C]雷氯必利结合降低可能是这种疾病有用的早期标志物。